A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis | MicrobiomeTrials

← Back to trials

NCT07013201

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2025-09-11Est. Completion: 2026-12-14

Enrollment target: 135 participants

Locations

LEO Pharma Investigational Site, Fountain Valley, California, United States
LEO Pharma Investigational Site, Douglasville, Georgia, United States
LEO Pharma Investigational Site, West Bloomfield, Michigan, United States
LEO Pharma Investigational Site, Elmhurst, New York, United States
LEO Pharma Investigation Site, Mayfield Heights, Ohio, United States
LEO Pharma Investigational Site, Portland, Oregon, United States
LEO Pharma Investigational Site, Philadelphia, Pennsylvania, United States
LEO Pharma Investigational Site, Calgary, Alberta, Canada
LEO Pharma Investigational Site, Edmonton, Alberta, Canada
LEO Pharma Investigational Site, Surrey, British Columbia, Canada
LEO Pharma Investigational Site, Winnipeg, Manitoba, Canada
LEO Pharma Investigational Site, Fredericton, New Brunswick, Canada
LEO Pharma Investigational Site, Hamilton, Ontario, Canada
LEO Pharma Investigational Site, Hamilton, Ontario, Canada
LEO Pharma Investigational Site, Markham, Ontario, Canada
LEO Pharma Investigational Site, Waterloo, Ontario, Canada

Other microbiome trials you might be interested in

A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated FlaresPhase 4Completed

Generalized Pustular Psoriasis

This study is open to adults with a serious skin disease called generalized pustular psoriasis (GPP) who have repeated f…

Irvine, United StatesCompleted May 13, 2026

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness RegistryRecruiting

Generalized Pustular Psoriasis

Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200…

Waltham, United StatesEst. completion Dec 2099

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.